$GSK 5 SEC Filings

Filed On	Filing
14 Feb 2014	Form 5: Glaxosmithkline Plc, 10% owner · NUPATHE INC. Received 1,516,806 shares by conversion
11 Feb 2008	Form 5: Glaxosmithkline Plc, 10% owner · Innoviva, Inc. Acquired 1 Class A common stock (Other Transaction) ($19.4)
13 Feb 2004	Form 5: Glaxosmithkline Plc, 10% owner · MAXYGEN INC Acquired 148,206 shares (Other Transaction)

Comments